Abstract
The diagnosis of advanced fibrosis in patients with liver disease is important in guiding both the initiation of screening for complications of cirrhosis and treatment decisions. Liver biopsy is still the current gold standard test for identifying advanced fibrosis; however, less-invasive tests have been described, including a serum test of aspartate aminotransferase to platelet ratio index (APRI) and Fibroscan, …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
